Get the Stockscreener App
4.37
1.80%
-0.08
After Hours:
4.45
0.08
+1.83%
Lipocine Inc Stock (LPCN) Forecast
The Lipocine Inc (LPCN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.24, representing a +248.80% increase from the current price of $4.37. The highest analyst price target is $14.89, and the lowest is $15.59.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LPCN Price Target
Average 9.9127
(+126.84% Upside)
Is Lipocine Inc (LPCN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.51 | Neutral |
| STOCH(9,6) | 14.31 | Buy |
| STOCHRSI(14) | 8.0402 | Buy |
| MACD(12,26) | -0.1089 | Sell |
| ADX(14) | 13.80 | Neutral |
| William %R | -90.40 | Buy |
| CCI(14) | -126.62 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.81
Sell
|
4.6807
Sell
|
| MA20 |
4.7944
Sell
|
4.7849
Sell
|
| MA50 |
4.9354
Sell
|
4.8969
Sell
|
| MA100 |
4.8291
Sell
|
4.9821
Sell
|
| MA200 |
5.4156
Sell
|
4.78
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, LPCN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on LPCN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.51 indicates that LPCN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.31 indicates that LPCN is oversold. This indicates that LPCN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.0402 indicates that LPCN is oversold. This suggests that LPCN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.8 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -126.62 indicates that LPCN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term LPCN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lipocine Inc financial reports and earnings history, Lipocine Inc (LPCN) stock could reach $26.15 by 2030, $21.12 by 2040 and $48.83 by 2050. See the projected annual prices until 2050 of the Lipocine Inc stock below:
- Lipocine Inc (LPCN) is expected to reach an average price of $9.7973 in 2035, with a high prediction of $10.34 and a low estimate of $9.8973. This indicates an $124.20% rise from the last recorded price of $4.37.
- Lipocine Inc (LPCN) stock is projected to chart a bullish course in 2040, with an average price target of $21.85, representing an $400.03% surge from its current level. The forecast ranges from a conservative $21.74 to a sky-high $21.12.
- Our analysts predict Lipocine Inc (LPCN) to jump 756.31% by 2045, soaring from $37.46 to an average price of $37.42, potentially reaching $37.11. While $37.46 is the low estimate, the potential upside is significant.
- Lipocine Inc (LPCN) stock is expected to climb by 2050, reaching an average of $42.07, a $862.79% jump from its current level. However, a wide range of estimates exists, with high and low targets of $48.83 and $45.30, respectively, highlighting the market's uncertainty.
Lipocine Inc Stock (LPCN) Year by Year Forecast
Lipocine Inc Stock (LPCN) Price Forecast for 2025
Lipocine Inc Stock (LPCN) is expected to reach an average price of $9.9127 in 2025, with a high prediction of $19.75 and a low estimate of $0.0745. This indicates an +126.84% rise from the last recorded price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $15.77 | $15.59 | $14.89 | +260.81% |
| March, 2025 | $14.78 | $15.54 | $15.10 | +238.27% |
| April, 2025 | $14.50 | $14.28 | $15.26 | +231.71% |
| May, 2025 | $12.65 | $14.01 | $14.49 | +189.44% |
| June, 2025 | $8.4299 | $10.55 | $12.66 | +92.90% |
| July, 2025 | $5.1903 | $6.9164 | $5.3947 | +18.77% |
| August, 2025 | $1.4406 | $0.4206 | $4.1606 | -67.03% |
| September, 2025 | $9.9075 | $1.2541 | $12.80 | +126.72% |
| October, 2025 | $1.2811 | $1.4389 | $19.75 | -70.68% |
| November, 2025 | $3.628 | $0.0745 | $7.1213 | -16.98% |
| December, 2025 | $0.4416 | $0.4084 | $6.5014 | -89.89% |
Lipocine Inc Stock (LPCN) Price Forecast for 2026
The predicted value for Lipocine Inc (LPCN) in 2026 is set at an average of $11.18. Estimates vary from a peak of $22.18 to a trough of $0.1783, indicating an +155.80% surge from the present price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.3785 | $0.1783 | $9.2485 | +68.84% |
| February, 2026 | $3.9454 | $1.8286 | $9.9886 | -9.72% |
| March, 2026 | $8.5022 | $2.2288 | $11.56 | +94.56% |
| April, 2026 | $11.61 | $9.089 | $22.18 | +165.58% |
| May, 2026 | $10.04 | $2.5793 | $14.29 | +129.81% |
| June, 2026 | $8.1396 | $4.7562 | $10.97 | +86.26% |
| July, 2026 | $4.4432 | $3.5932 | $8.8963 | +1.68% |
| August, 2026 | $5.2601 | $1.0267 | $7.3167 | +20.37% |
| September, 2026 | $6.1537 | $4.5038 | $8.8737 | +40.82% |
| October, 2026 | $6.3756 | $3.2306 | $7.7934 | +45.89% |
| November, 2026 | $5.9175 | $5.5775 | $8.9173 | +35.41% |
| December, 2026 | $2.4761 | $1.4644 | $6.3342 | -43.34% |
Lipocine Inc Stock (LPCN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lipocine Inc (LPCN) is $9.2327, with a high forecast of $18.39 and a low forecast of $0.0794. This indicates an +111.27% increase from the last price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.273 | $0.8632 | $5.588 | -47.99% |
| February, 2027 | $4.5348 | $1.4011 | $5.3081 | +3.77% |
| March, 2027 | $3.5584 | $1.3276 | $5.1817 | -18.57% |
| April, 2027 | $2.2605 | $1.1504 | $4.4686 | -48.27% |
| May, 2027 | $1.9792 | $0.1142 | $3.4922 | -54.71% |
| June, 2027 | $11.53 | $1.891 | $11.53 | +163.75% |
| July, 2027 | $9.6227 | $8.0927 | $18.39 | +120.20% |
| August, 2027 | $3.422 | $3.1313 | $9.9544 | -21.69% |
| September, 2027 | $1.6449 | $0.1335 | $5.5863 | -62.36% |
| October, 2027 | $1.0746 | $0.1651 | $3.4033 | -75.41% |
| November, 2027 | $0.9412 | $0.6126 | $2.2121 | -78.46% |
| December, 2027 | $0.0141 | $0.0794 | $2.2238 | -99.68% |
Lipocine Inc Stock (LPCN) Price Forecast for 2028
In 2028, Lipocine Inc (LPCN) is projected to reach an average price of $46.53, with a high projection of $92.23 and a low estimate of $0.8378. This indicates an +964.83% rise from the last price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9843 | $1.8727 | $1.4726 | -54.59% |
| February, 2028 | $3.7157 | $2.8991 | $3.0119 | -14.97% |
| March, 2028 | $4.0291 | $3.8255 | $3.6721 | -7.80% |
| April, 2028 | $2.573 | $3.3465 | $3.7331 | -41.12% |
| May, 2028 | $3.3947 | $3.4668 | $2.5978 | -22.32% |
| June, 2028 | $0.8047 | $1.1447 | $3.0477 | -81.59% |
| July, 2028 | $0.6848 | $0.8378 | $0.6513 | -84.33% |
| August, 2028 | $4.0667 | $1.6111 | $1.4249 | -6.94% |
| September, 2028 | $3.5473 | $3.7941 | $3.1158 | -18.83% |
| October, 2028 | $4.5495 | $4.0705 | $3.759 | +4.11% |
| November, 2028 | $3.7968 | $3.8635 | $92.23 | -13.12% |
| December, 2028 | $2.95 | $3.2566 | $3.2401 | -32.50% |
Lipocine Inc Stock (LPCN) Price Forecast for 2029
The 2029 price forecast for Lipocine Inc Stock (LPCN) is $10.44 on average, with a high prediction of $20.81 and a low estimate of $0.0692. This represents an +138.92% increase from the previous price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6364 | $3.1464 | $3.2785 | -39.67% |
| February, 2029 | $3.1495 | $2.6129 | $2.7595 | -27.93% |
| March, 2029 | $3.3526 | $3.3526 | $3.066 | -23.28% |
| April, 2029 | $3.8657 | $3.6959 | $3.7024 | -11.54% |
| May, 2029 | $3.8021 | $3.9488 | $3.9436 | -13.00% |
| June, 2029 | $3.3652 | $3.5652 | $3.5391 | -22.99% |
| July, 2029 | $2.8983 | $3.1751 | $3.1885 | -33.68% |
| August, 2029 | $1.4047 | $1.5797 | $2.5917 | -67.86% |
| September, 2029 | $1.1879 | $1.1546 | $1.13 | -72.82% |
| October, 2029 | $0.5742 | $0.7342 | $0.9311 | -86.86% |
| November, 2029 | $0.9626 | $0.0692 | $2.7659 | -77.97% |
| December, 2029 | $21.85 | $0.1694 | $20.81 | +399.92% |
Lipocine Inc Stock (LPCN) Price Forecast for 2030
Lipocine Inc Stock (LPCN) is expected to reach an average price of $21.76 in 2030, with a high forecast of $41.79 and a low forecast of $1.7309. This signifies an +397.98% surge from the last price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.64 | $22.87 | $26.15 | +463.74% |
| February, 2030 | $19.94 | $20.11 | $20.57 | +356.33% |
| March, 2030 | $20.35 | $20.16 | $19.45 | +365.63% |
| April, 2030 | $1.2995 | $6.9843 | $17.81 | -70.26% |
| May, 2030 | $2.8171 | $1.7309 | $8.1126 | -35.54% |
| June, 2030 | $4.0733 | $2.5268 | $5.9732 | -6.79% |
| July, 2030 | $41.66 | $3.0864 | $40.88 | +853.35% |
| August, 2030 | $42.20 | $41.57 | $41.79 | +865.57% |
| September, 2030 | $39.27 | $40.33 | $41.25 | +798.54% |
| October, 2030 | $38.63 | $38.88 | $38.35 | +784.02% |
| November, 2030 | $39.45 | $37.23 | $37.54 | +802.84% |
| December, 2030 | $38.16 | $37.97 | $37.98 | +773.31% |
0.65%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):